Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
36%
OVERLAP
BY WEIGHT
50
# OF OVERLAPPING
HOLDINGS
XPH
58
HOLDINGS
86%
ALSO IN IHE
IHE
55
HOLDINGS
100%
ALSO IN XPH
SECTOR DRIFT (XPH minus IHE)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XPH |
Weight in IHE |
Overlap | |
|---|---|---|---|---|
 |
CORCEPT THERAPEUTICS INC | 2.1% | 2.3% | 2.1% |
|
MERCK & CO. INC. | 1.9% | 5.1% | 1.9% |
|
BRISTOL-MYERS SQUIBB CO | 1.8% | 4.8% | 1.8% |
|
ROYALTY PHARMA PLC CLASS A | 1.8% | 4.7% | 1.8% |
|
JOHNSON & JOHNSON | 1.7% | 23.3% | 1.7% |
XPH Overweight Relative to IHE
|
AMYLYX PHARMACEUTICALS, INC. | 3.1% |
|
MBX BIOSCIENCES INC | 2.6% |
|
OMEROS CORP | 2.5% |
|
ETON PHARMACEUTICALS, INC. | 2.1% |
|
NUVATION BIO INC CLASS A | 1.9% |
|
ENLIVEN THERAPEUTICS, INC. | 1.7% |
 |
PERRIGO CO | 1.6% |
|
ALTO NEUROSCIENCE INC | 1.6% |
|
TREVI THERAPEUTICS, INC. | 1.5% |
|
PACIRA PHARMACEUTICALS INC | 1.5% |
XPH Underweight Relative to IHE
|
JOHNSON & JOHNSON | -21.5% |
|
ELI LILLY & CO | -18.9% |
|
MERCK & CO. INC. | -3.2% |
|
BRISTOL-MYERS SQUIBB CO | -3.0% |
|
ROYALTY PHARMA PLC CLASS A | -3.0% |
|
PFIZER INC | -2.8% |
|
VIATRIS, INC. | -2.7% |
|
ZOETIS INC | -2.4% |
|
JAZZ PHARMACEUTICALS PLC | -1.8% |
|
ELANCO ANIMAL HEALTH, INC. | -1.1% |